Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Limited Competition: Regenerative Medicine Innovation…

U.S. National Institutes of Health·United States of America

Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional)

Closes 12/9/2025$500k – $2MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institute of Arthritis and Musculoskeletal and Skin Diseases intends to publish a Notice of Funding Opportunity to solicit applications for continuing research on advancing the field of regenerative medicine using adult stem cells. This opportunity will utilize the UH3 activity code and is limited to investigators who have been previously funded through the Regenerative Medicine Innovation Project. The goal of this project is to support innovative research that will advance the field of regenerative medicine. • The opportunity is open to various types of organizations, including private institutions of higher education, public and state controlled institutions of higher education, small businesses, and non-profits. • The estimated application response date is Oct 21, 2025. • The estimated award date is Jun 22, 2026. • The estimated project start date is Jul 21, 2026.

Attached files

Contact

Aron Marquitz

[email protected]

(301) 435-1240

Key dates

Opened
6/9/2025
Closes
12/9/2025
Projected award
6/22/2026

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-AR-25-014

Budget estimate

$500,000 – $2,000,000

The budget for this grant is not explicitly stated in the document. However, based on the information provided, it can be estimated that the budget will be in the range of $500,000 to $2 million, considering the funding for similar research projects in the past. The actual budget may vary depending on the scope and complexity of the proposed research project.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 78%

Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)

Closes 5/26/2029Opened 9/17/2025

U.S. National Institutes of Health·United States of America

77% match

Limited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed)

Closes 7/16/2029Opened 5/5/2025

U.S. National Institutes of Health·United States of America

77% match

Limited Competition: Supporting Programs to Advance Research Knowledge in Environmental Health Sciences (SPARK-EHS) (UE5/T32 - Clinical Trial Not Allowed)

Closes 12/6/2026Opened 6/26/2026

U.S. National Institutes of Health·United States of America

76% match

Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)

Closes 1/25/2027Opened 2/19/2026

U.S. National Institutes of Health·United States of America

75% match

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

Closes 10/19/2027Opened 12/11/2024

U.S. National Institutes of Health·United States of America

75% match

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/4/2024

U.S. National Institutes of Health·United States of America

75% match

Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)

Closes 1/24/2027Opened 7/16/2026

U.S. National Institutes of Health·United States of America

75% match

Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)

Closes 11/5/2027Opened 10/28/2024

U.S. National Institutes of Health·United States of America

75% match

Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships

Closes 6/16/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

75% match

Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)

Closes 5/30/2029Opened 11/19/2025

U.S. National Institutes of Health·United States of America

75% match

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

Closes 11/13/2026Opened 2/1/2024

U.S. National Institutes of Health·United States of America

75% match

Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

Closes 2/15/2027Opened 7/1/2026

U.S. National Institutes of Health·United States of America

75% match

Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)

Closes 11/10/2026Opened 6/25/2026

U.S. National Institutes of Health·United States of America

74% match

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 1/13/2026

U.S. National Institutes of Health·United States of America

74% match

Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science

Closes 1/24/2027Opened 7/20/2026

U.S. National Institutes of Health·United States of America

74% match

Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)

Closes 1/7/2028Opened 9/12/2022

U.S. National Institutes of Health·United States of America

74% match

Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)

Closes 11/7/2028Opened 7/18/2025

U.S. National Institutes of Health·United States of America

74% match

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Closes 2/20/2029Opened 5/28/2025

U.S. National Institutes of Health·United States of America

74% match

Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)

Closes 1/26/2029Opened 8/27/2025

U.S. National Institutes of Health·United States of America

74% match

Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

Closes 7/5/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

74% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. National Institutes of Health·United States of America

74% match

Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)

Closes 10/13/2028Opened 7/1/2025

U.S. National Institutes of Health·United States of America

74% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

74% match

HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)

Closes 11/23/2026Opened 9/3/2024

U.S. National Institutes of Health·United States of America

74% match

R3PEATS Grassroots Rigor Projects: Individual Metascience and Individual Laboratory Capacity-Building (RP1)

Closes 9/30/2027Opened 9/11/2026